SRC and diabetic retinopathy: It was reported that miR-383 inhibits the apoptosis of retinal pigment epithelial cells in diabetic retinopathy [39] and inhibits proliferation, migration, and angiogenesis of endothelial cells exposed to gliomas through VEGF-mediated FAK and Src signaling pathways [40].